Bruker’s unique analytical methods and technological systems drive innovation in the fast growing fields of genomics, proteomics and metabolomics.
Life sciences are changing rapidly and constantly. New discoveries lead to more efficient methods and speed up the development of small and large molecule therapeutics – thus creating a basis for sustainable growth in these markets.
With innovative solutions Bruker supports pharmaceutical companies, research institutes and development organizations in driving therapeutical advancements, managing costs, expanding analytical capabilities and significantly increasing productivity.
No reviews to display
Bruker Daltonics Inc. to Exhibit impact and New compact qTOF for Forensics and Doping Control Solutions at Pittcon 2013
04 Mar 2013
14 Dec 2006
03 Jul 2006
07 Mar 2006
Bruker Daltonics Announces Microorganism Identification and Classification Application Based on Mass Spectrometry
03 Jan 2006